Plasma Proteomics for Risk Prediction and Therapeutic Target Discovery in Crohn’s Disease and Ulcerative Colitis

This study identifies novel plasma protein associations with CD and UC, supported by genetic evidence, and highlights their potential as therapeutic targets. Plasma proteomics significantly improves risk prediction for incident CD and UC compared to traditional clinical models, offering new avenues for drug discovery and personalized risk assessment.